FDA Clearance Tracker · K171214
Infrared Thermometer
Last checked: Nov 20, 2026Latest source record: Mar 2, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Mar 2, 2018
Substantially Equivalent
Time to decision
311 days
Received Apr 25, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K171214
- Device name
- Infrared Thermometer
- Applicant location
- Shenzhen, CN
- Received
- Apr 25, 2017
- Decided
- Mar 2, 2018
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Continuous Measurement Thermometer (FLL)
- Device class
- Class II
- Regulation
- 21 CFR 880.2910
- Specialty
- Hospital Medicine & Nursing
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code FLL. The earliest in FDA's data is K760118, decided Jul 20, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K171214
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Shenzhen Brav Electronic Technologies Co., Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260470 · Decided Oct 1, 2026 · 231 days after receipt
Device type: System, Measurement, Blood-Pressure, Non-Invasive (DXN) · Cardiology
- Pulse Oximeter510(k)
K211143 · Decided Jul 17, 2023 · 822 days after receipt
Device type: Oximeter (DQA) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.